Flag of the European Union EU Clinical Trials Register Help

Clinical trials for NA

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    26,261 result(s) found for: NA. Displaying page 100 of 1,314.
    «« First « Previous 96  97  98  99  100  101  102  103  104  Next» Last»»
    EudraCT Number: 2008-002578-36 Sponsor Protocol Number: 2008/0817 Start Date*: 2008-09-10
    Sponsor Name:CHRU de LILLE
    Full Title: Etude d’efficacité et d’acceptabilité d’un traitement cholinergique dans l’apathie parkinsonienne “Cholinergic treatment in Parkinsonian Apathy: ChoPA - I”
    Medical condition: Parkinsonian Apathy without dementia and depression in spite of dopaminergic treatment
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2009-011906-40 Sponsor Protocol Number: 27659 Start Date*: 2009-06-22
    Sponsor Name:Radboud University Nijmegen Medical Centre
    Full Title: The use of antibiotics in therapy resistant Lichen Sclerosus patientes
    Medical condition: Vulvar Lichen Sclerosus
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-024558-12 Sponsor Protocol Number: CRPS-1-2011-2014 Start Date*: 2011-02-17
    Sponsor Name:Aalto-yliopiston Kylmälaboratorion Aivotutkimusyksikkö
    Full Title: CRPS-potilaiden aivomuutosten korjaantuminen hoidon myötä
    Medical condition: Complex regional pain syndrome tyyppi 1 eli CRPS-I -potilaita
    Disease: Version SOC Term Classification Code Term Level
    12.1 10064334 Complex regional pain syndrome Type I LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2005-001218-42 Sponsor Protocol Number: 177/2004/U/Sper Start Date*: 2005-01-17
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Clinical role of PPAR gamma activator (pioglitazone) in reducing the gastric phlogosis in patiens with istological gastritis.
    Medical condition: Treatment of patients with gastric phlogosis (infected by Helicobacter pylori)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10017904 Gastroenteritis helicobacter LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-002705-38 Sponsor Protocol Number: 1/2008 Start Date*: 2009-03-20
    Sponsor Name:HARRAS Pharma Curarina Arzneimittel GmbH
    Full Title: Double-randomized and controlled clinical trial in children to assess the efficacy and safety of Symphytum herb extract cream 10% against 1% in the acceleration of wound healing
    Medical condition: Wound healing
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000838-21 Sponsor Protocol Number: 34/04 Start Date*: 2004-10-22
    Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI
    Full Title: RANDOMIZED STUDY OF RADIOTHERAPY WITH CONCOMITANT BOOST (RTcb) AND CONCURRENT LOW DOSE CISPLATIN VS RTcb AND CISPLATIN + FLUOROURACIL IN ADVANCED HNSCC
    Medical condition: Head and neck cancer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030969 Oral cavity neoplasms NEC HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001605-10 Sponsor Protocol Number: INT 17/04 Start Date*: 2004-04-27
    Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI
    Full Title: A Phase II, open-label study of PTK787/ZK222584 in the treatment of metastatic gastrointestinal stromal tumors GISTs resistant to imatinib mesylate
    Medical condition: Metastatic gastrointestinal stromal tumors GISTs
    Disease: Version SOC Term Classification Code Term Level
    6.1 10017992 HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003911-63 Sponsor Protocol Number: GERT Start Date*: 2006-01-12
    Sponsor Name:University of Heidelberg, Frau I. Gürkan, Kaufmännische Direktorin
    Full Title: Combined Radiochemotherapy with Erbitux (Cetuximab) plus Temozolomide in the primary therapy of Glioblastoma Multiforme (GBM) - Phase I/II Trial
    Medical condition: Glioblastoma Multiforme (GBM)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002825-37 Sponsor Protocol Number: 31.8.2004 Start Date*: 2004-11-08
    Sponsor Name:Tays/ anestesiayksikkö
    Full Title: Levosimendaanin vaikutus systeemiseen ja splanknikusalueen verenkiertoon vatsa-aortan anyrysman vuoksi leikattavilla potilailla
    Medical condition: Leikkaushoitoa vaativa elektiivinen aortta-aneyrymapotilas
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2005-001258-26 Sponsor Protocol Number: CVAH631B2406 E1 Start Date*: 2006-03-14
    Sponsor Name:Novartis Faarmacéutica S.A
    Full Title: Extensión de 8 semanas de duración del estudio multicéntrico, aleatorizado, doble ciego, de grupos paralelos, de control activo, de 14 semanas de duración para evaluar la efectividad de la estrateg...
    Medical condition: Essential hypertension
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) DK (Completed) GB (Completed) IE (Completed) IT (Completed) DE (Completed) FI (Completed)
    Trial results: View results
    EudraCT Number: 2005-005967-27 Sponsor Protocol Number: ASL605LIOM03 PROMET Start Date*: 2006-10-31
    Sponsor Name:AZIENDA USL 6 LIVORNO ZONA LIVORNESE
    Full Title: Study pilot of metronomic chemotherapy with ciclofosfamide, celecoxib and desametasone in patients with diagnosis of carcinoma of the refractory ormon prostate in advanced stage appraisal pharmac...
    Medical condition: ORMONO REFRACTORY CARCINOMA OF PROSTATE IN ADVANCED STAGE
    Disease: Version SOC Term Classification Code Term Level
    6.1 10007280 PT
    Population Age: Elderly Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001818-16 Sponsor Protocol Number: LT-CLL-001 Start Date*: 2007-07-05
    Sponsor Name:Vilnius University Hospital Santariskiu Clinics
    Full Title: Phase II Study of High-dose Methylprednisolone and Rituximab in Previously Treated Patients with High Risk Chronic B Lymphocytic Leukemia
    Medical condition: Treated high-risk chronic B lymphocytic leukemia.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003947 B-Lymphocytic, CLL (Kiel Classification) recurrent LLT
    9.1 10003948 B-Lymphocytic, CLL (Kiel Classification) refractory LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-001384-11 Sponsor Protocol Number: captaf Start Date*: 2008-04-03
    Sponsor Name:
    Full Title: Catheter Ablation compared with Pharmacological Therapy for Atrial Fibrillation – the CAPTAF trial
    Medical condition: To study the effect of catheter ablation (using CE marked products) on the quality of life an in patients with atrial fibrillation depsite treatment with conevntional antiarrhythmic medical therapy...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066664 Recurrent symptomatic atrial fibrillation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-007075-16 Sponsor Protocol Number: GE07-12 Start Date*: 2008-12-01
    Sponsor Name:VU university medical center
    Full Title: The effect of peroxisome proliferator activator receptor γ agonist pre-treatment on pegylated interferon-α2a and ribavirin efficacy in hepatitis C patients, previously resistant to treatment with p...
    Medical condition: Chronic hepatitis C infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008912 Chronic hepatitis C LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-005045-35 Sponsor Protocol Number: CLAF237A2327 Start Date*: 2005-02-17
    Sponsor Name:Novartis Sverige AB
    Full Title: A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with LAF237 50 mg bid to rosiglitazone 8 mg qd in drug naïve patients with type 2 diabetes
    Medical condition: Type II Diabetes
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2007-007315-93 Sponsor Protocol Number: V00071 GM 101 1A Start Date*: 2008-03-25
    Sponsor Name:Pierre Fabre dermatologie
    Full Title: Human skin blanching essay comparing a new shampoo containing betamethasone dipropionate at 0.025% and 0.050% to three reference marketed formulations in healthy subjects
    Medical condition: As it's a Mc Kensie and Stoughton test, there is no medical condition to be investigated in this trial. The intended indication for the betamethasone dipropionate shampoo is seborrhoeic dermatitis ...
    Disease:
    Population Age: Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2005-001143-31 Sponsor Protocol Number: CNS-242 Ph2/2 Start Date*: 2005-07-13
    Sponsor Name:Nippon Suisan Kaisha, Ltd
    Full Title: A Phase II, Multicentre, Double-blind, Parallel Group 8 Week Study to Assess the Efficacy and Safety of Two Doses of CNS-242 in Lowering Serum Uric Acid (SUA) and Preventing Gout Attacks in Gout Pa...
    Medical condition: Gout/Hyperuricaemia
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004912-30 Sponsor Protocol Number: aprepitant1 Start Date*: 2008-07-31
    Sponsor Name:Karolinska Institutet
    Full Title: Modulation of opiate reward by NK1 antagonism: A laboratory based proof of concept study
    Medical condition: opiate abuse
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039004 Reversal of opiate activity LLT
    9.1 10012346 Dependence on opiates LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-000703-18 Sponsor Protocol Number: S1713012 Start Date*: 2004-10-27
    Sponsor Name:SOLVAY PHARMACEUTICALS GMBH
    Full Title: A multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan respectively Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure le...
    Medical condition: Essential hypertension with associated Diabetes Mellitus type 2.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001994-24 Sponsor Protocol Number: atorvastatin Start Date*: 2004-11-09
    Sponsor Name:Karolinska Institute Danderyd Hospital
    Full Title: Effects of atorvastatin on plasma fibrin gel structure and skin microvascular reactivity in patients with type 1 diabetes and dyslipidemia
    Medical condition: Hyperlipidemia in patients with diabetes seems associated with a thrombogenic plasma fibrin gel structure and impaired microvascular function. We hypothesize that lipid lowering with a statin leads...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 96  97  98  99  100  101  102  103  104  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed Jun 18 07:30:04 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA